NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Wave Life Sciences Ltd (NASDAQ: WVE)

 
WVE Technical Analysis
4
As on 9th Jun 2023 WVE STOCK Price closed @ 4.09 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.88 & Strong Buy for SHORT-TERM with Stoploss of 2.72 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

WVESTOCK Price

Open 4.11 Change Price %
High 4.21 1 Day -0.02 -0.49
Low 4.07 1 Week 0.43 11.75
Close 4.09 1 Month 0.13 3.28
Volume 159277 1 Year 0.93 29.43
52 Week High 7.00 | 52 Week Low 1.23
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
WVE
Daily Charts
WVE
Intraday Charts
Whats New @
Bazaartrend
WVE
Free Analysis
 
WVE Important Levels Intraday
RESISTANCE4.36
RESISTANCE4.27
RESISTANCE4.22
RESISTANCE4.17
SUPPORT4.01
SUPPORT3.96
SUPPORT3.91
SUPPORT3.82
 
WVE Forecast May 2024
4th UP Forecast6.44
3rd UP Forecast5.69
2nd UP Forecast5.22
1st UP Forecast4.75
1st DOWN Forecast3.43
2nd DOWN Forecast2.96
3rd DOWN Forecast2.49
4th DOWN Forecast1.74
 
WVE Weekly Forecast
4th UP Forecast5.40
3rd UP Forecast4.98
2nd UP Forecast4.72
1st UP Forecast4.46
1st DOWN Forecast3.72
2nd DOWN Forecast3.46
3rd DOWN Forecast3.20
4th DOWN Forecast2.78
 
WVE Forecast2024
4th UP Forecast15.56
3rd UP Forecast11.88
2nd UP Forecast9.61
1st UP Forecast7.33
1st DOWN Forecast0.85
2nd DOWN Forecast-1.43
3rd DOWN Forecast-3.7
4th DOWN Forecast-7.38
 
 
WVE Other Details
Segment EQ
Market Capital 227451392.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
WVE Address
WVE
 
WVE Latest News
 
Your Comments and Response on Wave Life Sciences Ltd
 
WVE Business Profile
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore. Address: Marina One East Tower, Singapore, Singapore, 018936
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service